RxDB
ICD-9-CM Codes ICD-9-PCS Codes

0010 - Implantation of chemotherapeutic agent

Overview

GEM Conversion to ICD-10 PCS

Fs: 10000 – Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach
Fs: 10000 – Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Muscle, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach
Fs: 10000 – Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Bones, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach
Fs: 10000 – Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening

Sibling Codes

Implantation of chemotherapeutic agent
Infusion of drotrecogin alfa (activated)
Administration of inhaled nitric oxide
Injection or infusion of nesiritide
Injection or infusion of oxazolidinone class of antibiotics
High-dose infusion interleukin-2 [IL-2]
Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance
Infusion of vasopressor agent
Infusion of immunosuppressive antibody therapy
Disruption of blood brain barrier via infusion [BBBD]